FDA Approved: RISEDRONATE SODIUM — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for Risendronate Sodium from Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucocorticoid-induced Osteoporosis
• Paget Disease of Bone
• Postmenopausal Osteoporosis

Drugs mentioned

• RISENDRONATE SODIUM (risendronate sodium)

Snippet

SUPPL AP for RISEDRONATE SODIUM (RISEDRONATE SODIUM)